Human Natural Killer Cells: Formation and Structure of Activating Synapses
人类自然杀伤细胞:激活突触的形成和结构
基本信息
- 批准号:7587340
- 负责人:
- 金额:$ 41.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-30 至 2012-02-29
- 项目状态:已结题
- 来源:
- 关键词:ActinsAutoimmune DiseasesB-LymphocytesCellsCytolysisCytoplasmic GranulesExocytosisGoalsHumanImmune systemInhibitory SynapseKnowledgeLeadMultiprotein ComplexesNatural Killer CellsNonmuscle Myosin Type IIAPeripheralPhosphorylationPhosphorylation SiteProteinsRoleSignal PathwayStructureSynapsesTumor Virus InfectionsVirus DiseasesWiskott-Aldrich Syndromeimmunological synapsetumor
项目摘要
DESCRIPTION (provided by applicant): Natural killer cells are part of the innate immune system, the primary defense against virus infections and tumors. They may also have a role in activating autoimmune diseases. They lyse their target through forming an activating immunological synapse or they are inhibited by forming an inhibitory synapse with these cells. The goal of this project is to understand how the immunological synapses are formed and how they function. This knowledge may help us to enhance (in the case of virus infection or tumors) or diminish (in the case of autoimmune diseases) their cytolytic activity in circumstances in which this may be desired. The Specific Aim of this proposal is to examine the formation and function of immunological synapses in human Natural Killer (NK) cells by: 1. Identifying the protein components of the actin ring in the peripheral supermolecular activation cluster of the activating NK synapse and the mechanism by which this multiprotein complex is formed, particularly the role of Wiscott-Aldrich Syndrome interacting protein (WIP) and its phosphorylation sites. 2. Studying the signaling pathways that lead to formation of the activating immunological synapse, particularly the phosphorylation of synaptic components and their functions. 3. Defining the role of Myosin IIA and IIB in granule exocytosis, the last step that leads to cytolysis of target cells.
描述(由申请人提供):自然杀伤细胞是先天免疫系统的一部分,是对抗病毒感染和肿瘤的主要防御系统。它们也可能在激活自身免疫性疾病中发挥作用。它们通过形成激活性免疫突触来裂解它们的靶细胞,或者通过与这些细胞形成抑制性突触来抑制它们。这个项目的目标是了解免疫突触是如何形成的,以及它们是如何发挥作用的。这些知识可以帮助我们在可能需要的情况下增强(在病毒感染或肿瘤的情况下)或减少(在自身免疫性疾病的情况下)它们的细胞溶解活性。本提案的具体目的是通过以下方式研究人类自然杀伤(NK)细胞中免疫突触的形成和功能:1。确定激活NK突触的外周超分子激活簇中肌动蛋白环的蛋白质组分和形成这种多蛋白复合物的机制,特别是Wiscott-Aldrich综合征相互作用蛋白(Wiscott-Aldrich Syndrome interacting protein,WISC-Aldrich Syndrome interacting protein,WISC-Aldrich Syndrome interacting protein,WISC-Aldrich Syndrome interacting protein)及其磷酸化位点的作用。2.研究导致激活免疫突触形成的信号通路,特别是突触成分的磷酸化及其功能。3.定义肌球蛋白IIA和IIB在颗粒胞吐中的作用,这是导致靶细胞溶解的最后一步。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JACK L STROMINGER其他文献
JACK L STROMINGER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JACK L STROMINGER', 18)}}的其他基金
Human Decidual Leukocytes and Their Placental Ligands
人蜕膜白细胞及其胎盘配体
- 批准号:
8296572 - 财政年份:2003
- 资助金额:
$ 41.12万 - 项目类别:
Human Decidual Leukocytes and Their Placental Ligands
人蜕膜白细胞及其胎盘配体
- 批准号:
8685873 - 财政年份:2003
- 资助金额:
$ 41.12万 - 项目类别:
Human Decidual Lymphocytes and their Placental Ligands
人蜕膜淋巴细胞及其胎盘配体
- 批准号:
6685460 - 财政年份:2003
- 资助金额:
$ 41.12万 - 项目类别:
Human Decidual Leukocytes and Their Placental Ligands
人蜕膜白细胞及其胎盘配体
- 批准号:
7987848 - 财政年份:2003
- 资助金额:
$ 41.12万 - 项目类别:
Human Decidual Lymphocytes and their Placental Ligands
人蜕膜淋巴细胞及其胎盘配体
- 批准号:
6983437 - 财政年份:2003
- 资助金额:
$ 41.12万 - 项目类别:
Human Decidual Leukocytes and Their Placental Ligands
人蜕膜白细胞及其胎盘配体
- 批准号:
8094379 - 财政年份:2003
- 资助金额:
$ 41.12万 - 项目类别:
Human Decidual Leukocytes and Their Placental Ligands
人蜕膜白细胞及其胎盘配体
- 批准号:
8496486 - 财政年份:2003
- 资助金额:
$ 41.12万 - 项目类别:
Human Decidual Lymphocytes and their Placental Ligands
人蜕膜淋巴细胞及其胎盘配体
- 批准号:
6830760 - 财政年份:2003
- 资助金额:
$ 41.12万 - 项目类别:
Human Decidual Lymphocytes and their Placental Ligands
人蜕膜淋巴细胞及其胎盘配体
- 批准号:
7149145 - 财政年份:2003
- 资助金额:
$ 41.12万 - 项目类别:
Human Decidual Lymphocytes and their Placental Ligands
人蜕膜淋巴细胞及其胎盘配体
- 批准号:
6756606 - 财政年份:2003
- 资助金额:
$ 41.12万 - 项目类别:
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
- 批准号:
479128 - 财政年份:2023
- 资助金额:
$ 41.12万 - 项目类别:
Operating Grants
Effects of maternal immune activation on autoimmune diseases in offsprings
母体免疫激活对后代自身免疫性疾病的影响
- 批准号:
23H02155 - 财政年份:2023
- 资助金额:
$ 41.12万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
IPP: AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC)
IPP:自身免疫性疾病统计和临床协调中心 (ADSCCC)
- 批准号:
10788032 - 财政年份:2023
- 资助金额:
$ 41.12万 - 项目类别:
Biomarkers of vascular endothelial dysfunction in systemic autoimmune diseases: analysis of circulating microRNAs
系统性自身免疫性疾病中血管内皮功能障碍的生物标志物:循环 microRNA 分析
- 批准号:
23K14742 - 财政年份:2023
- 资助金额:
$ 41.12万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
NOVEL HUMORAL AND CELLULAR BIOMARKERS OF AUTOIMMUNE DISEASES CAUSED BY IMMUNOTHERAPY
免疫治疗引起的自身免疫性疾病的新型体液和细胞生物标志物
- 批准号:
10593224 - 财政年份:2023
- 资助金额:
$ 41.12万 - 项目类别:
Structural mechanisms of autoimmune diseases targeting cys-loop receptors
针对半胱氨酸环受体的自身免疫性疾病的结构机制
- 批准号:
10864719 - 财政年份:2023
- 资助金额:
$ 41.12万 - 项目类别:
Developing non-immunosuppressive immune-based therapeutics for targeted treatment of autoimmune diseases
开发非免疫抑制性免疫疗法来靶向治疗自身免疫性疾病
- 批准号:
10586562 - 财政年份:2023
- 资助金额:
$ 41.12万 - 项目类别:
Regulation of autoimmune diseases by PTPN22 phosphatase
PTPN22磷酸酶对自身免疫性疾病的调节
- 批准号:
23K06589 - 财政年份:2023
- 资助金额:
$ 41.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Decipher and target GABA metabolism and GABA receptor-mediated signaling in autoimmune diseases
破译并靶向自身免疫性疾病中的 GABA 代谢和 GABA 受体介导的信号传导
- 批准号:
10623380 - 财政年份:2023
- 资助金额:
$ 41.12万 - 项目类别:
Targeting the long isoform of the prolactin receptor to treat autoimmune diseases and B-cell malignancies
靶向催乳素受体的长亚型来治疗自身免疫性疾病和 B 细胞恶性肿瘤
- 批准号:
10735148 - 财政年份:2023
- 资助金额:
$ 41.12万 - 项目类别: